The Canadian Cancer Clinical Trials Network

The Canadian Cancer Clinical Trials Network (3CTN) is a pan-Canadian initiative to improve the efficiency and quality of clinical trials in Canada. 3CTN will provide support and coordination for a network of teams at cancer treatment centres and hospitals. With regional participation, 3CTN will enable sites to increase their capacity and capability to conduct academic trials.

Meet our partners

3CTN Stakeholder Meeting

The Canadian Cancer Clinical Trials Network held its stakeholder meeting on November 6, 2015 in Toronto. View the slide deck for more information.

ZIP, 9 MB application/zip icon

3CTN Guide to Patient and Public Involvement (PPI)

In collaboration with the 3CTN Lay Representative Advisory Committee, 3CTN is pleased to release a new document that will serve the cornerstone of the PPI Program – download the 3CTN Guide to PPI below.

3CTN Guide to PPI


The table below provides an overview on reporting obligations and timelines for 3CTN award recipients.

Reporting Obligations for 3CTN Award Recipients

3CTN Newsletter

November 18, 2015

3CTN has released its November Newsletter. View this issue for more information on 3CTN Progress to date.

November 2015 Newsletter →